Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126]

Similar Items

• Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites
  od: Engel, Jessica A., i dr.
  Izdano: (2015)
• Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
  od: Jesus, Jessica A., i dr.
  Izdano: (2017)
• Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
  od: Gomes, Ana Rita, i dr.
  Izdano: (2017)
• Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities’ [Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222]
  od: Geyer, Kathrin K., i dr.
  Izdano: (2018)
• Corrigendum to “Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms” [Int. J. Parasitol. Drugs Drug Resist. 23 (2023) 94–105]
  od: Alexandra Kahl, i dr.
  Izdano: (2024-12-01)